Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: A review of 5 clinical studies. Adv Ther. 2006 Jan 1;23(1):179-190

 

Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol. 1998;134(11):1356-1360

 

Ismail Kücükkurt , Sinan Ince , Hikmet Keles, Esra Küpeli Akkol, Gülcan Avci, Erdem Yesilada, Elif Bacak. Beneficial effects of Aesculus hippocastanum L. seed extract on the body’s own antioxidant defense system on subacute administration. J Ethnopharmacol. 2010 May 4;129(1):18-22

 

Ottillinger B, Greeske K. Rational therapy of chronic venous insufficiency – chances and limits of the therapeutic use of horse-chestnut seeds extract. BMC Cardiovasc Disord. 2001 Dec 7;1(1)

 

Zhang Z, Li S, Lian XY. An Overview of Genus Aesculus L.: Ethnobotany, Phytochemistry, and Pharmacological Activities. Pharm Crops. 2010;1:24-51

 

Carrasco O. F. and H. Vidrio. 2007. Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta.  Vascul. Pharmacol. 47(1): 68–73.

 

Dickson S., J. Gallagher, L. McIntyre, A. Suter and J. Tan. 2004. An open study to assess the safety and efficacy of Aesculus hippocastanum tablets (Aesculaforce 50mg) in the treatment of chronic venous insufficiency. J. Herb. Pharmacother. 4(2): 19–32.

 

Konoshima T and K. H. Lee. 1986. Antitumor agents, 82. Cytotoxic sapogenols from Aesculus hippocastanum. J. Nat. Prod. 49(4): 650–656.

 

MacKay D.  2001. Hemorrhoids and varicose veins: a review of treatment options.  Altern. Med. Rev. 6(2):126–140.

 

Matsuda H., Y. Li, T. Murakami, K. Ninomiya, J. Yamahara and M. Yoshikawa. 1997.  Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol. Pharm. Bull 20(10): 1092–1095.